Health

Patients with axial spondyloarthritis (axSpA) are accustomed to regular follow-up appointments in order to manage their condition effectively. However, a recent randomized trial conducted by Dr. Inger Jorid Berg and her team at Diakonhjemmet Hospital in Oslo, Norway, revealed that patients who initiated follow-up contacts with their clinicians actually fared no worse medically compared to
The issue of air pollution is not limited to its impact on the environment; it also poses a significant threat to human health, especially for expectant mothers. Recent studies have highlighted the alarming connection between maternal exposure to particulate matter (PM) and adverse pregnancy outcomes, particularly in relation to blood pressure complications. These findings shed
The study conducted by Dr. Erminia Massarelli, MD, PhD, focused on evaluating the effectiveness of osimertinib (Tagrisso) in combination with consolidative stereotactic ablative radiation (SABR) for treating advanced EGFR-mutant non-small cell lung cancer (NSCLC). This trial was presented at the American Society of Clinical Oncology (ASCO) meeting and aimed to determine the impact of this
Machine translation tools such as Google Translate and ChatGPT have gained popularity for their quick and convenient translations of text from one language to another. However, a recent study published in Pediatrics found that while these tools performed well for languages like Spanish and Brazilian Portuguese, they fell short in accurately translating Haitian Creole, particularly
The FDA advisory committee’s unanimous support for the investigational drug donanemab for treating early Alzheimer’s disease marks a significant milestone in the field of Alzheimer’s research. The committee’s 11-0 vote in favor of donanemab’s benefits outweighing its risks for patients with mild cognitive impairment and mild dementia enrolled in clinical trials opens up new possibilities
As Rep. Jamie Raskin (D-Md.) highlights, the investigation on COVID-19’s origins sheds light on the complexities of managing healthcare crises. The statement emphasizes the importance of transparency and accountability in healthcare decision-making processes. Such challenges require a collaborative effort from experts in the field. The acquisition of physician-owned practices by private equity groups, as experienced
Tirzepatide, a weight loss and diabetes drug, has shown promising results in resolving metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis. The SYNERGY-NASH phase II study revealed significant improvements among participants with biopsy-confirmed MASH and fibrosis, highlighting the potential of this novel therapy. The treatment regimen estimand demonstrated that tirzepatide led to the resolution of MASH